PL338434A1 - Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite
- Google Patents
Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst FarmaceutycznyfiledCriticalInst Farmaceutyczny
Priority to PL338434ApriorityCriticalpatent/PL195489B1/en
Publication of PL338434A1publicationCriticalpatent/PL338434A1/en
Publication of PL195489B1publicationCriticalpatent/PL195489B1/en
PL338434A2000-02-152000-02-15Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite
PL195489B1
(en)
Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite
Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite
Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite
Improved prolonged release pharmaceutic preparation for administration of nephadosone, oral dosage form thereof and improved nephadosone administration method
Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate
Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite